Ascendis Pharma A/S (ASND)

234.95 +9.95 (+4.42%) USD  |  NASDAQ  |  Feb 23, 16:00
235.00 +0.05 (+0.02%) After-Hours: 19:59
More

Ascendis Pharma Ending Cash (Quarterly)

Ending Cash (Quarterly) Chart

View Ending Cash (Quarterly) for ASND.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Ending Cash (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Ending Cash (Quarterly) Range, Past 5 Years

View Ending Cash (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Ending Cash (Quarterly) Benchmarks

View Ending Cash (Quarterly) Benchmarks
Start Trial
Novo Nordisk A/S Upgrade
Evaxion AS --
DBV Technologies SA Upgrade
Cellectis SA Upgrade
Biodexa Pharmaceuticals Plc --